These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 27886918)

  • 1. Cardiac Resynchronization Therapy: An Overview on Guidelines.
    Boriani G; Nesti M; Ziacchi M; Padeletti L
    Heart Fail Clin; 2017 Jan; 13(1):117-137. PubMed ID: 27886918
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiac Resynchronization Therapy: An Overview on Guidelines.
    Boriani G; Nesti M; Ziacchi M; Padeletti L
    Card Electrophysiol Clin; 2015 Dec; 7(4):673-93. PubMed ID: 26596811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiac resynchronization therapy: How did consensus guidelines from Europe and the United States evolve in the last 15 years?
    Boriani G; Ziacchi M; Nesti M; Battista A; Placentino F; Malavasi VL; Diemberger I; Padeletti L
    Int J Cardiol; 2018 Jun; 261():119-129. PubMed ID: 29657035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiac resynchronization therapy in women: US Food and Drug Administration meta-analysis of patient-level data.
    Zusterzeel R; Selzman KA; Sanders WE; Caños DA; O'Callaghan KM; Carpenter JL; Piña IL; Strauss DG
    JAMA Intern Med; 2014 Aug; 174(8):1340-8. PubMed ID: 25090172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. QRS duration, bundle-branch block morphology, and outcomes among older patients with heart failure receiving cardiac resynchronization therapy.
    Peterson PN; Greiner MA; Qualls LG; Al-Khatib SM; Curtis JP; Fonarow GC; Hammill SC; Heidenreich PA; Hammill BG; Piccini JP; Hernandez AF; Curtis LH; Masoudi FA
    JAMA; 2013 Aug; 310(6):617-26. PubMed ID: 23942680
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness of Cardiac Resynchronization Therapy by QRS Morphology in the Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy (MADIT-CRT).
    Zareba W; Klein H; Cygankiewicz I; Hall WJ; McNitt S; Brown M; Cannom D; Daubert JP; Eldar M; Gold MR; Goldberger JJ; Goldenberg I; Lichstein E; Pitschner H; Rashtian M; Solomon S; Viskin S; Wang P; Moss AJ;
    Circulation; 2011 Mar; 123(10):1061-72. PubMed ID: 21357819
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relation of QRS Duration to Clinical Benefit of Cardiac Resynchronization Therapy in Mild Heart Failure Patients Without Left Bundle Branch Block: The Multicenter Automatic Defibrillator Implantation Trial with Cardiac Resynchronization Therapy Substudy.
    Biton Y; Kutyifa V; Cygankiewicz I; Goldenberg I; Klein H; McNitt S; Polonsky B; Ruwald AC; Ruwald MH; Moss AJ; Zareba W
    Circ Heart Fail; 2016 Feb; 9(2):e002667. PubMed ID: 26823498
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of QRS duration and morphology on cardiac resynchronization therapy outcomes in mild heart failure: results from the Resynchronization Reverses Remodeling in Systolic Left Ventricular Dysfunction (REVERSE) study.
    Gold MR; Thébault C; Linde C; Abraham WT; Gerritse B; Ghio S; St John Sutton M; Daubert JC
    Circulation; 2012 Aug; 126(7):822-9. PubMed ID: 22781424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. QRS frequency characteristics help predict response to cardiac resynchronization in left bundle branch block less than 150 milliseconds.
    Niebauer MJ; Rickard J; Polakof L; Tchou PJ; Varma N
    Heart Rhythm; 2014 Dec; 11(12):2183-9. PubMed ID: 25068573
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of QRS morphology and duration on outcomes after cardiac resynchronization therapy: Results from the Resynchronization-Defibrillation for Ambulatory Heart Failure Trial (RAFT).
    Birnie DH; Ha A; Higginson L; Sidhu K; Green M; Philippon F; Thibault B; Wells G; Tang A
    Circ Heart Fail; 2013 Nov; 6(6):1190-8. PubMed ID: 23995437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiac resynchronization therapy in women versus men: observational comparative effectiveness study from the National Cardiovascular Data Registry.
    Zusterzeel R; Spatz ES; Curtis JP; Sanders WE; Selzman KA; Piña IL; Bao H; Ponirakis A; Varosy PD; Masoudi FA; Caños DA; Strauss DG
    Circ Cardiovasc Qual Outcomes; 2015 Mar; 8(2 Suppl 1):S4-11. PubMed ID: 25714821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Canadian Cardiovascular Society guidelines on the use of cardiac resynchronization therapy: evidence and patient selection.
    Exner DV; Birnie DH; Moe G; Thibault B; Philippon F; Healey JS; Tang AS; Larose É; Parkash R
    Can J Cardiol; 2013 Feb; 29(2):182-95. PubMed ID: 23351926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relation of QRS duration to response to cardiac resynchronization therapy.
    Sassone B; Gambetti S; Bertini M; Beltrami M; Mascioli G; Bressan S; Fucà G; Pacchioni F; Pedaci M; Michelotti F; Bacchi Reggiani ML; Padeletti L
    Am J Cardiol; 2015 Jan; 115(2):214-9. PubMed ID: 25465934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of mechanical dyssynchrony in cardiac resynchronization therapy.
    Risum N
    Dan Med J; 2014 Dec; 61(12):B4981. PubMed ID: 25441737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiac Resynchronization Therapy in Women.
    Costanzo MR
    Heart Fail Clin; 2017 Jan; 13(1):165-178. PubMed ID: 27886921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. QRS axis and the benefit of cardiac resynchronization therapy in patients with mildly symptomatic heart failure enrolled in MADIT-CRT.
    Brenyo A; Rao M; Barsheshet A; Cannom D; Quesada A; McNitt S; Huang DT; Moss AJ; Zareba W
    J Cardiovasc Electrophysiol; 2013 Apr; 24(4):442-8. PubMed ID: 23252875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of QRS duration on clinical event reduction with cardiac resynchronization therapy: meta-analysis of randomized controlled trials.
    Sipahi I; Carrigan TP; Rowland DY; Stambler BS; Fang JC
    Arch Intern Med; 2011 Sep; 171(16):1454-62. PubMed ID: 21670335
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Site of latest activation in patients eligible for cardiac resynchronization therapy: patterns of dyssynchrony among different QRS configurations and impact of heart failure etiology.
    van Bommel RJ; Ypenburg C; Mollema SA; Borleffs CJ; Delgado V; Bertini M; Marsan NA; van der Wall EE; Schalij MJ; Bax JJ
    Am Heart J; 2011 Jun; 161(6):1060-6. PubMed ID: 21641351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Do cardiologists follow the European guidelines for cardiac pacing and resynchronization therapy? Results of the European Heart Rhythm Association survey.
    Sciaraffia E; Dagres N; Hernandez-Madrid A; Proclemer A; Todd D; Blomström-Lundqvist C
    Europace; 2015 Jan; 17(1):148-51. PubMed ID: 25552672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sex Differences in Long-Term Outcomes With Cardiac Resynchronization Therapy in Mild Heart Failure Patients With Left Bundle Branch Block.
    Biton Y; Zareba W; Goldenberg I; Klein H; McNitt S; Polonsky B; Moss AJ; Kutyifa V;
    J Am Heart Assoc; 2015 Jun; 4(7):. PubMed ID: 26124205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.